Vascular Calcification: Current Genetics Underlying This Complex Phenomenon

Nonanzit Pérez-Hernández1, Gad Aptilon-Duque1, Ruben Blachman-Braun1

  • 1Department of Molecular Biology, National Institute of Cardiology "Ignacio Chávez", México, Mexico City 14080, México.

Insights

Genetic factors significantly influence vascular calcification, a complex condition involving calcium deposition. Understanding these genetic contributions and molecular pathways is crucial for better disease management.

Area of Science:

  • Cardiovascular Research
  • Genetics and Molecular Biology
  • Pathophysiology

Background:

  • Vascular calcification involves calcium deposition in blood vessel walls, linked to conditions like diabetes and kidney disease.
  • Individual variations in vascular calcification severity suggest a significant genetic component.
  • Pathophysiology is multifactorial, involving genetic variants, molecular pathways, and environmental factors.

Purpose of the Study:

  • To review recent evidence on the genetic aspects and molecular pathways of vascular calcification pathophysiology.
  • To explore the genetic contribution to the variability in vascular calcification.

Main Methods:

  • Conducted an exhaustive literature search in Scopus, EBSCO, and PubMed.
  • Keywords included "genetics and vascular calcification" and "molecular pathways, genetic and vascular calcification".
  • Focused on original and review articles published from January 1995 to August 2016.

Main Results:

  • Vascular calcification is a multifactorial disease, not attributable to a single factor.
  • Development results from an interplay of genetic variants, molecular pathway interactions, and environmental influences.
  • The degree of calcification varies due to the complex interaction of these factors.

Conclusions:

  • While some molecular mechanisms are understood, a comprehensive understanding of predisposing factors is lacking.
  • Further research into the genetic and molecular underpinnings of vascular calcification is warranted.
  • Identifying genetic predispositions may improve therapeutic strategies.
Abstract

Related Concept Videos

Overview of the Vascular System01:20

Overview of the Vascular System

The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
3.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
65
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
60
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.3K